DUBLIN--(BUSINESS WIRE)--Dec. 19, 2013--
plc (NYSE: COV) will report first-quarter fiscal 2014 results on January
24, 2014. The company will host a conference call for investors at 8:30
a.m. ET. The call can be accessed in the following ways:
Via webcast at Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those
participants who wish to take part in the question-and-answer portion
of the call, the telephone dial-in number in the U.S. is 866-318-8619.
For participants outside the U.S., the dial-in number is 617-399-5138.
The access code for all callers is 23284490.
Through an audio replay: A replay of the conference call will be
available beginning at 11:30 a.m. ET on January 24, 2014, and ending
at 5 p.m. on January 31, 2014. The dial-in number for U.S.
participants is 888-286-8010. For participants outside the U.S., the
replay dial-in number is 617-801-6888. The replay access code for all
callers is 38477785.
The company will issue a news release announcing financial results for
the fiscal first quarter on January 24, prior to the conference call.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.
Source: Covidien plc
Peter Lucht, 508-452-4168
Lannum, CFA, 508-452-4343